PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1733
https://www.valueinhealthjournal.com/article/S1098-3015(18)35035-6/fulltext
Title :
PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35035-6&doi=10.1016/j.jval.2018.09.1733
First page :
Section Title :
Open access? :
No
Section Order :
1097